#OCEGynCancers18 Conference Hashtag

FDA-AACR-SGO Workshop on Drug Development in Gynecologic Malignancies

Gynecologic malignancies continue to be a major cause of morbidity and mortality in the United States, resulting in an unmet medical need. In 2015, FDA held a public workshop to facilitate drug development in gynecologic malignancies, with a focus on ovarian cancer, where we covered topics including immunotherapy, novel clinical trial designs, novel endpoints, and expanded eligibility criteria. Th
Conference Website

#OCEGynCancers18 is a conference hashtag submitted by @AACRPres